Baldini, C., Champiat, S., Vuagnat, P., & Massard, C. (2019). Durvalumab for the management of urothelial carcinoma: A short review on the emerging data and therapeutic potential. Onco Targets Ther.
Citação norma ChicagoBaldini, Capucine, Stéphane Champiat, Perrine Vuagnat, and Christophe Massard. "Durvalumab for the Management of Urothelial Carcinoma: A Short Review On the Emerging Data and Therapeutic Potential." Onco Targets Ther 2019.
Citação norma MLABaldini, Capucine, Stéphane Champiat, Perrine Vuagnat, and Christophe Massard. "Durvalumab for the Management of Urothelial Carcinoma: A Short Review On the Emerging Data and Therapeutic Potential." Onco Targets Ther 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.